Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials
about
Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next DecadeGenetic testing for CYP450 polymorphisms to predict response to clopidogrel: current evidence and test availability. Application: pharmacogenomics.Antiplatelet combinations for prevention of atherothrombotic eventsRisk of Stroke in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention versus Optimal Medical Therapy: Systematic Review and Meta-Analysis of Randomized Controlled Trials.Predictive models for short- and long-term adverse outcomes following discharge in a contemporary population with acute coronary syndromesExpanding the recognition and assessment of bleeding events associated with antiplatelet therapy in primary care.Safety and tolerability of antiplatelet therapies for the secondary prevention of atherothrombotic disease.The evolution of antiplatelet therapy in cardiovascular disease.Importance of potent P2Y(12) receptor blockade in acute myocardial infarction: focus on prasugrel.Challenges and limitations in the interpretation of systematic reviews: making sense of clopidogrel and CYP2C19 pharmacogenetics.Cost-effectiveness of clopidogrel: seeing through the smoke.Interaction between clopidogrel and proton-pump inhibitors and management strategies in patients with cardiovascular diseases.Clopidogrel resistance - a clear problem with an unclear solution
P2860
Q28392069-4123F674-7A9C-43C7-A5C8-CC9B46BFC1CDQ33704998-67100820-17B0-4B3F-8A54-993FA8D4A603Q34566264-64270966-BB07-426B-B293-7A0202F48CEFQ36071090-4B9999BC-5EE9-4971-8697-6105731A0181Q36645766-EF8FE6C7-F46D-4488-8DDA-D105D5BF0333Q37148386-DA4EB0EA-782E-4B74-BD9A-0142F5EF899BQ37532491-AE2D8EE9-F7B2-4B63-919F-BCAFDC938018Q37900470-1108099C-41A7-4992-A7CF-A07699AF3284Q38025446-C44079E2-A566-47B2-9050-79B030914EA5Q38106616-BAD80FA8-933F-49BA-AAE7-9EA0F73D5C25Q40080904-5D24565F-CCF1-449A-B6D4-A26B94CC37DFQ42731681-D91316B3-DB85-467B-976C-6C21DBCC6D42Q42803407-12063A62-A10F-4591-8C0C-3A5FC450B2FB
P2860
Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Incremental effect of clopidog ...... -analysis of randomized trials
@ast
Incremental effect of clopidog ...... -analysis of randomized trials
@en
Incremental effect of clopidog ...... -analysis of randomized trials
@nl
type
label
Incremental effect of clopidog ...... -analysis of randomized trials
@ast
Incremental effect of clopidog ...... -analysis of randomized trials
@en
Incremental effect of clopidog ...... -analysis of randomized trials
@nl
prefLabel
Incremental effect of clopidog ...... -analysis of randomized trials
@ast
Incremental effect of clopidog ...... -analysis of randomized trials
@en
Incremental effect of clopidog ...... -analysis of randomized trials
@nl
P2093
P2860
P3181
P1476
Incremental effect of clopidog ...... -analysis of randomized trials
@en
P2093
Anthony A Bavry
Deepak L Bhatt
Dharam J Kumbhani
Henri Roukoz
Sandeep Duggal
Thomas J Helton
P2860
P304
P3181
P356
10.2165/00129784-200707040-00006
P407
P577
2007-01-01T00:00:00Z
P6179
1013012789